Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefania Pizzimenti

Showing results (41-50 of 72) with videos related to

Pageof 8
Sort By:
Free Radical Biology & Medicine|April 25, 2006
4-Hydroxynonenal inhibits telomerase activity and hTERT expression in human leukemic cell linesStefania Pizzimenti, Federica Briatore, Stefano Laurora, et al.
Antioxidants & Redox Signaling|November 4, 2014
Role of 4-hydroxynonenal-protein adducts in human diseasesGiuseppina Barrera, Stefania Pizzimenti, Eric Stefano Ciamporcero, et al.
Antioxidants (Basel, Switzerland)|February 25, 2016
Mitochondrial Dysfunction in Cancer and Neurodegenerative Diseases: Spotlight on Fatty Acid Oxidation and Lipoperoxidation ProductsGiuseppina Barrera, Fabrizio Gentile, Stefania Pizzimenti, et al.
PPAR Research|May 24, 2012
AS601245, an Anti-Inflammatory JNK Inhibitor, and Clofibrate Have a Synergistic Effect in Inducing Cell Responses and in Affecting the Gene Expression Profile in CaCo-2 Colon Cancer CellsAngelo Cerbone, Cristina Toaldo, Stefania Pizzimenti, et al.
Plos One|July 5, 2012
Rosiglitazone and AS601245 decrease cell adhesion and migration through modulation of specific gene expression in human colon cancer cellsAngelo Cerbone, Cristina Toaldo, Rosalba Minelli, et al.
Pharmaceutics|March 29, 2023
Exploiting Nanomedicine for Cancer Polychemotherapy: Recent Advances and Clinical ApplicationsElena Boggio, Casimiro Luca Gigliotti, Ian Stoppa, et al.
Antioxidants (Basel, Switzerland)|October 17, 2020
Carbosilane Dendrimers Loaded with siRNA Targeting Nrf2 as a Tool to Overcome Cisplatin Chemoresistance in Bladder Cancer CellsLeanne Ambrosio, Monica Argenziano, Marie Angèle Cucci, et al.
Cancers|January 16, 2020
Improvement in the Anti-Tumor Efficacy of Doxorubicin Nanosponges in In Vitro and in Mice Bearing Breast Tumor ModelsMonica Argenziano, Casimiro Luca Gigliotti, Nausicaa Clemente, et al.
Nanomaterials (Basel, Switzerland)|December 11, 2022
Parenteral Nanoemulsions Loaded with Combined Immuno- and Chemo-Therapy for Melanoma TreatmentChiara Monge, Ian Stoppa, Chiara Ferraris, et al.
Free Radical Biology & Medicine|August 6, 2011
Nuclear factor erythroid 2-related factor-2 activity controls 4-hydroxynonenal metabolism and activity in prostate cancer cellsPiergiorgio Pettazzoni, Eric Ciamporcero, Claudio Medana, et al.
Pageof 8

Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
Free Radical Biology & Medicine|April 25, 2006
4-Hydroxynonenal inhibits telomerase activity and hTERT expression in human leukemic cell linesStefania Pizzimenti, Federica Briatore, Stefano Laurora, et al.
Antioxidants & Redox Signaling|November 4, 2014
Role of 4-hydroxynonenal-protein adducts in human diseasesGiuseppina Barrera, Stefania Pizzimenti, Eric Stefano Ciamporcero, et al.
Antioxidants (Basel, Switzerland)|February 25, 2016
Mitochondrial Dysfunction in Cancer and Neurodegenerative Diseases: Spotlight on Fatty Acid Oxidation and Lipoperoxidation ProductsGiuseppina Barrera, Fabrizio Gentile, Stefania Pizzimenti, et al.
PPAR Research|May 24, 2012
AS601245, an Anti-Inflammatory JNK Inhibitor, and Clofibrate Have a Synergistic Effect in Inducing Cell Responses and in Affecting the Gene Expression Profile in CaCo-2 Colon Cancer CellsAngelo Cerbone, Cristina Toaldo, Stefania Pizzimenti, et al.
Plos One|July 5, 2012
Rosiglitazone and AS601245 decrease cell adhesion and migration through modulation of specific gene expression in human colon cancer cellsAngelo Cerbone, Cristina Toaldo, Rosalba Minelli, et al.
Pharmaceutics|March 29, 2023
Exploiting Nanomedicine for Cancer Polychemotherapy: Recent Advances and Clinical ApplicationsElena Boggio, Casimiro Luca Gigliotti, Ian Stoppa, et al.
Antioxidants (Basel, Switzerland)|October 17, 2020
Carbosilane Dendrimers Loaded with siRNA Targeting Nrf2 as a Tool to Overcome Cisplatin Chemoresistance in Bladder Cancer CellsLeanne Ambrosio, Monica Argenziano, Marie Angèle Cucci, et al.
Cancers|January 16, 2020
Improvement in the Anti-Tumor Efficacy of Doxorubicin Nanosponges in In Vitro and in Mice Bearing Breast Tumor ModelsMonica Argenziano, Casimiro Luca Gigliotti, Nausicaa Clemente, et al.
Nanomaterials (Basel, Switzerland)|December 11, 2022
Parenteral Nanoemulsions Loaded with Combined Immuno- and Chemo-Therapy for Melanoma TreatmentChiara Monge, Ian Stoppa, Chiara Ferraris, et al.
Free Radical Biology & Medicine|August 6, 2011
Nuclear factor erythroid 2-related factor-2 activity controls 4-hydroxynonenal metabolism and activity in prostate cancer cellsPiergiorgio Pettazzoni, Eric Ciamporcero, Claudio Medana, et al.
Pageof 8